| Literature DB >> 35911809 |
Arup Ratan Das1, K C Vidya1, M V Srikar1, Jugajyoti Pathi1, Aryan Jaiswal2.
Abstract
Introduction: The low-level laser therapy has been accepted globally as cell bio-modulator, used to reach ideal therapeutic effects, acting in the reduction of the pain response, with anti-inflammatory effects, stimulating local micro-circulation and wounds repair, promoting a rapid recovery, which brings a better quality of life to the patient. In this study, we aim to to determine the effectiveness of low-level laser therapy on reducing the pain and swelling after removal of impacted third molars. Materials andEntities:
Keywords: Low-level laser; postoperative pain; surgical removal; third molar
Year: 2022 PMID: 35911809 PMCID: PMC9326211 DOI: 10.4103/njms.njms_297_21
Source DB: PubMed Journal: Natl J Maxillofac Surg ISSN: 0975-5950
Figure 1Laser exposure for intra-oral sites after the surgery
Figure 2Laser exposure for extra oral sites after the surgery. (a) Point A (b) Point B (c) Point C
Comparison of 1st and 7th day time points with pain status in control group and study group by Wilcoxon matched pairs test
| Groups | Changes from | Percentage of change |
|
|
|---|---|---|---|---|
| Control group | 1st day to 7th day | 50.00 | 3.2958 | 0.0010* |
| Study group | 1st day to 7th day | 85.71 | 3.1798 | 0.0015* |
*P<0.05
Comparison of control group and study group with pain status at 1st and 7th day time points by Mann–Whitney U-test
| Pain at | Control group (%) | Study group (%) | Total (%) |
|
|
|---|---|---|---|---|---|
| 1st day | |||||
| Mild pain | 0 | 9 (60.00) | 9 (30.00) | −3.7952 | 0.0001* |
| Moderate pain | 7 (46.67) | 6 (40.00) | 13 (43.33) | ||
| Severe pain | 8 (53.33) | 0 | 8 (26.67) | ||
| Total | 15 (100.00) | 15 (100.00) | 30 (100.00) | ||
| 7th day | |||||
| No pain | 0 | 12 (80.00) | 12 (40.00) | −3.9818 | 0.0001* |
| Mild pain | 11 (73.33) | 3 (20.00) | 14 (46.67) | ||
| Moderate pain | 4 (26.67) | 0 | 4 (13.33) | ||
| Total | 15 (100.00) | 15 (100.00) | 30 (100.00) |
*P value <0.05 is significant
Comparison of 1st and 7th day time points with supero-inferior edema coefficient, antero-posterior edema coefficient and mouth opening (mm) in control group and study group by dependent t-test
| Groups | Time | Mean | SD | Mean difference | SD difference | Percentage of change | Paired |
|
|---|---|---|---|---|---|---|---|---|
| Supero-inferior edema coefficient | ||||||||
| Control group | 1st day | 12.63 | 6.88 | 5.96 | 3.13 | 47.20 | 7.3857 | 0.0001* |
| 7th day | 6.67 | 5.39 | ||||||
| Study group | 1st day | 10.30 | 6.45 | 4.39 | 6.50 | 42.65 | 2.6179 | 0.0203* |
| 7th day | 5.91 | 3.85 | ||||||
| Antero-posterior edema coefficient | ||||||||
| Control group | 1st day | 8.83 | 4.73 | 4.56 | 3.02 | 60.48 | 5.8574 | 0.0001* |
| 7th day | 4.07 | 2.21 | ||||||
| Study group | 1st day | 7.54 | 4.19 | 4.75 | 4.22 | 53.85 | 4.3584 | 0.0007* |
| 7th day | 2.98 | 2.45 | ||||||
| Mouth opening (mm) | ||||||||
| Control group | 1st day | 32.80 | 12.19 | +6.13 | 4.07 | +23.00 | +5.838 | 0.0001* |
| 7th day | 26.67 | 88 | ||||||
| Study group | 1st day | 32.53 | 1.88 | +6.07 | 2.49 | +18.65 | +9.429 | 0.0001* |
| 7th day | 38.60 | 2.06 | ||||||
*P<0.05. SD: Standard deviation